GFC Life Science revises asset revaluation plan, raising land book value to 5,727,672,961 won

• GFC Life Science corrected its voluntary disclosure on a planned land asset revaluation to add an additional parcel.
• The updated revaluation scope includes a newly registered Dongtan A-PAC City unit, added following the Sept. 28 decision.
• Book value of the revaluation 대상 assets was revised to 5,727,672,961 won from 5,685,757,140 won, based on Sept. 28 figures.
• The revaluation remains set with a Sept. 28, 2026 기준일, with Taepyeongyang Appraisal as the valuation firm.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GFC Life Science Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261002900755), on October 02, 2026, and is solely responsible for the information contained therein.